BILL NUMBER: AB 1073	AMENDED
	BILL TEXT

	AMENDED IN ASSEMBLY  APRIL 6, 2015

INTRODUCED BY   Assembly Member Ting

                        FEBRUARY 27, 2015

   An act to  amend   add  Section 
4076.5 of   4076.6 to  the Business and
Professions Code,   and to add Section 1714.20 to the Civil Code,
  relating to pharmacy.


	LEGISLATIVE COUNSEL'S DIGEST


   AB 1073, as amended, Ting. Pharmacy: prescription drug labels.
   The Pharmacy Law provides for the licensure and regulation of
pharmacists by the California State Board of Pharmacy. That law
requires the board to promulgate regulations that require, on or
before January 1, 2011, a standardized, patient-centered,
prescription drug label on all prescription medicine dispensed to
patients in California. Existing regulations of the board implement
that requirement.  A violation of that law is a crime. 
   This bill would  remove that obsolete date.  
require a dispenser to use a standardized direction for use on the
label of the prescription   container from a list in
existing regulations. The bill would require the board to make
available translations, in a minimum of 5 languages other than
English, of those standardized directions for use and post the
translated standardized directions for use on its Internet Web site.
The bill would require a dispenser, upon request of a patient for a
translated direction for use, to select the appropriate translated
standardized direction for use, if available, and append it to the
label on the patient's prescription container or provide it on a
supplemental document. The bill would authorize a dispenser to
provide his or her own translated directions as an alternative to the
above-described procedure. By imposing new requirements on
dispensers, the violation of which would be a crime, this bill would
impose a state-mandated local program.  
   The bill would exempt from civil liability a dispenser who
complies with the requirement to select the appropriate translated
standardized direction for use, if available, and append it to the
label, for any error that results from the inability of the dispenser
to understand a translated direction for use in a language other
than English.  
   The California Constitution requires the state to reimburse local
agencies and school districts for certain costs mandated by the
state. Statutory provisions establish procedures for making that
reimbursement.  
   This bill would provide that no reimbursement is required by this
act for a specified reason. 
   Vote: majority. Appropriation: no. Fiscal committee:  no
  yes  . State-mandated local program:  no
  yes  .


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

   SECTION 1.    Section 4076.6 is added to the 
 Business and Professions Code   , to read: 
    4076.6.    (a) For all dangerous drugs dispensed to
patients in this state, when applicable, a dispenser shall use a
standardized direction for use on the label of the prescription
container from the list in subdivision (a) of Section 1707.5 of Title
16 of the California Code of Regulations.  
   (b) The board shall make available translations, in a minimum of
five languages other than English, of the standardized directions for
use that are listed in subdivision (a) of Section 1707.5 of Title 16
of the California Code of Regulations. These translations shall be
approved by qualified translators, as determined by the board. The
board shall post these translated standardized directions for use on
its Internet Web site.  
   (c) Upon the request of a patient for a translated direction for
use, a dispenser shall select the appropriate translated standardized
direction for use from those established in accordance with
subdivision (b), if available, and append it to the label on the
patient's prescription container or provide it on a supplemental
document. If a translated direction for use appears on a prescription
container label, the English version of the direction shall also
appear on the label. The translated direction for use shall appear in
the patient-centered area of the label in accordance with
subdivision (a) of Section 1707.5 of Title 16 of the California Code
of Regulations. The English version may appear in an area of the
label outside the patient-centered area.  
   (d) A dispenser may provide his or her own translated directions
as an alternative to the procedure established in subdivisions (a) to
(c), inclusive. The translated directions for use shall appear in
the patient-centered area of the label in accordance with subdivision
(a) of Section 1707.5 of Title 16 of the California Code of
Regulations or a supplemental document. The English version may
appear in other areas of the label outside the patient-centered area.

   SEC. 2.    Section 1714.20 is added to the  
Civil Code   ,  immediately following Section 1714.2
 , to read: 
    1714.20.    A dispenser who complies with
subdivision (c) of Section 4076.6 of the Business and Professions
Code shall not be liable for civil damages for any error that results
from the inability of the dispenser to understand a translated
direction for use in a language other than English. 
   SEC. 3.    No reimbursement is required by this act
pursuant to Section 6 of Article XIII B of the California
Constitution because the only costs that may be incurred by a local
agency or school district will be incurred because this act creates a
new crime or infraction, eliminates a crime or infraction, or
changes the penalty for a crime or infraction, within the meaning of
Section 17556 of the Government Code, or changes the definition of a
crime within the meaning of Section 6 of Article XIII B of the
California Constitution.  
  SECTION 1.    Section 4076.5 of the Business and
Professions Code is amended to read:
   4076.5.  (a) The board shall promulgate regulations that require a
standardized, patient-centered, prescription drug label on all
prescription medicine dispensed to patients in California.
   (b) To ensure maximum public comment, the board shall hold public
meetings statewide that are separate from its normally scheduled
hearings in order to seek information from groups representing
consumers, seniors, pharmacists or the practice of pharmacy, other
health care professionals, and other interested parties.
   (c) When developing the requirements for prescription drug labels,
the board shall consider all of the following factors:
   (1) Medical literacy research that points to increased
understandability of labels.
   (2) Improved directions for use.
   (3) Improved font types and sizes.
   (4) Placement of information that is patient-centered.
   (5) The needs of patients with limited English proficiency.
   (6) The needs of senior citizens.
   (7) Technology requirements necessary to implement the standards.
   (d) The board may exempt from the regulations promulgated pursuant
to subdivision (a) prescriptions dispensed to a patient in a health
facility, as defined in Section 1250 of the Health and Safety Code,
if the prescriptions are administered by a licensed health care
professional. Prescriptions dispensed to a patient in a health
facility that will not be administered by a licensed health care
professional or that are provided to the patient upon discharge from
the facility shall be subject to this section and the regulations
promulgated pursuant to subdivision (a). Nothing in this subdivision
shall alter or diminish existing statutory and regulatory informed
consent, patients' rights, or pharmaceutical labeling and storage
requirements, including, but not limited to, Section 1418.9 of the
Health and Safety Code or Section 72357, 72527, or 72528 of Title 22
of the California Code of Regulations.
   (e) (1) The board may exempt from the regulations promulgated
pursuant to subdivision (a) a prescription dispensed to a patient if
all of the following apply:
   (A) The drugs are dispensed by a JCAHO-accredited home infusion or
specialty pharmacy.
   (B) The patient receives health-professional-directed education
before the beginning of therapy by a nurse or pharmacist.
   (C) The patient receives weekly or more frequent followup contacts
by a nurse or pharmacist.
   (D) Care is provided under a formal plan of care based upon a
physician and surgeon's orders.
   (2) For purposes of paragraph (1), home infusion and specialty
therapies include parenteral therapy or other forms of administration
that require regular laboratory and patient monitoring.